0.60 USD
▲-0.06+44.28%
盘后 0.39 -5.69%
2026-08-03
市值
$3.75M
市盈率
—
EPS
-17.09
股息率
—
52 周区间
0.25 – 14.14
成交量
55.55M
Beta
0.76
目标价
—
52W 低 0.2552W 高 14.14
价格走势
公司简介
GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.